Life-threatening complications from doxorubicin-docetaxel chemotherapy for breast cancer

JAMA. 2005 Nov 2;294(17):2166; author reply 2166-7. doi: 10.1001/jama.294.17.2166-a.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Antineoplastic Combined Chemotherapy Protocols / adverse effects*
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use
  • Breast Neoplasms / drug therapy*
  • Chemotherapy, Adjuvant
  • Docetaxel
  • Doxorubicin / administration & dosage
  • Doxorubicin / adverse effects
  • Granulocyte Colony-Stimulating Factor / therapeutic use
  • Humans
  • Neutropenia
  • Taxoids / administration & dosage
  • Taxoids / adverse effects

Substances

  • Taxoids
  • Granulocyte Colony-Stimulating Factor
  • Docetaxel
  • Doxorubicin